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Gastrointestinal (GI) bleeding is a common clinical condition that 
is increasingly seen in an aging population and frequently requires 
hospitalization and intervention, with significant morbidity and 
mortality. Obscure GI bleeding (OGIB) is defined as loss of blood 
with no source identified after upper endoscopy and colonoscopy. 
Whether an obscure site of bleeding is clinically evident or silent, it 
constitutes a diagnostic and therapeutic challenge for the clinician. 
Gastroenterology and radiology provide the essential diagnostic tools 
used to evaluate suspected OGIB, each with its strengths and weak-
nesses. Small bowel series and conventional enteroclysis have a limited 
role in OGIB. Computed tomographic (CT) enterography and CT 
enteroclysis are noninvasive techniques with promising results in eval-
uation of small bowel disease and silent OGIB. CT angiography is a 
useful triaging tool for diagnosing or excluding active GI hemorrhage, 
localizing the site of bleeding, and guiding subsequent treatment. 
Tagged red blood cell scanning is the most sensitive technique for 
detection of active GI bleeding and allows imaging over a prolonged 
period, making it useful for detecting intermittent bleeding. Capsule 
endoscopy has emerged as an important tool for investigating OGIB, 
but it may soon have competition from double-balloon enteroscopy, a 
diagnostic technique that can also facilitate therapy.
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introduction
The management of gastrointestinal (GI) bleed-
ing often involves a multispecialty approach in 
which radiologists and gastroenterologists play a 
key role, providing several specialized diagnostic 
examinations with a variety of imaging modalities 
as well as therapeutic interventions. The ultimate 
objective is to localize, characterize, and, when 
indicated, treat the bleeding lesion.
Obscure GI bleeding (OGIB) refers to bleeding 
from the GI tract that persists or recurs without an 
obvious cause after esophagogastroduodenoscopy 
and colonoscopy. OGIB may be categorized into 
obscure overt bleeding and obscure silent bleeding 
on the basis of the presence or absence of clini-
cally evident bleeding. Silent OGIB may manifest 
as amounts of blood detectable only with chemi-
cal tests in the stool or as iron deficiency anemia. 
Overt OGIB is high-volume bleeding manifesting 
as hematemesis, melena, or hematochezia without 
an identified source after initial upper endoscopy 
and colonoscopy (1,2).
GI bleeding leads to more than 300,000 hospi-
talizations per year. Approximately 10%–20% of 
these patients do not have an identified bleeding 
source, leading to extensive testing (3). In this 
article, we present an overview of the diagnos-
tic imaging modalities used in OGIB, including 
small bowel series and conventional enteroclysis, 
computed tomography (CT), CT enterography 
and enteroclysis, CT angiography, radionuclide 
imaging, catheter-directed angiography, wireless 
capsule endoscopy, and double-balloon enter-
oscopy. We also describe a rational diagnostic 
approach in patients with OGIB according to the 
clinical presentation.
Causes of OGiB
The source of OGIB may be attributable to any 
of a number of different causes (Table), including 
missed lesions in the upper and lower GI tract. 
The age of the patient is an important factor in 
the differential diagnosis of a small intestinal 
source of OGIB (5).
Determining the origin of the bleeding source 
in OGIB is a challenging clinical problem. Ap-
proximately 5% of patients presenting with GI 
bleeding have no source identified at esophago-
gastroduodenoscopy and colonoscopy; most 
of these patients will have small bowel disease 
identified (6,7). Small bowel vascular lesions 
are the most common cause. The most common 
pathologic lesions in this group are angiodys-
plasias, found in 30%–60% of examinations (8). 
Of unknown cause, these lesions are relatively 
common throughout the GI tract. Small bowel 
tumors are the next most common small bowel 
lesion causing OGIB and account for 5%–10% 
of cases of small bowel bleeding (9). Other less 
common causes of bleeding include small bowel 
ulcers (eg, Crohn disease, use of nonsteroidal 
anti-inflammatory drugs, Meckel diverticulum), 
vasculitis, small bowel diverticula, aortoenteric 
fistulas, and caliber-persistent arteries of the 
stomach (Dieulafoy lesion) (4).
imaging Techniques
Small Bowel Series  
and Conventional enteroclysis
The role of small bowel series and conventional 
enteroclysis in the evaluation of OGIB has 
declined substantially with the advent of newer 
imaging techniques owing to the low diagnostic 
yield of the former two techniques (10). Available 
data suggest that unless malignancy or Crohn 
disease is suspected, small bowel series and 
conventional enteroclysis have little use in the 
evaluation of OGIB (4).
Computed Tomography
With the development of multidetector technol-
ogy with submillimeter collimation and faster 
scanning speeds, CT now has the potential to 
Causes of OGiB
Upper GI lesions Cameron erosions Fundic varices Peptic ulcer Angiectasia Dieulafoy lesion Gastric antral vascular ectasia
Middle GI lesions In patients <40 years of age  Tumors  Meckel diverticulum  Dieulafoy lesion  Crohn disease  Celiac disease In patients >40 years of age  Angiectasia  NSAID* enteropathy  Celiac disease Uncommon lesions  Hemobilia  Hemosuccus pancreaticus  Aortoenteric fistula
Lower GI lesions Angiectasia Neoplasms
Sources.—References 1 and 4. 
*NSAID = nonsteroidal anti-inflammatory drug.
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Figure 1. Small bowel involvement in a 34-year-old woman with systemic lupus erythematosus who presented with 
lower abdominal pain, diarrhea, weight loss, anemia, and positive results from a fecal occult blood test. Axial enteric 
phase (a) and portal venous phase (b) CT images show ascites and marked mural thickening and target appearance 
of a small bowel loop (arrow), findings consistent with small bowel involvement by systemic lupus erythematosus.
play a role in evaluation of patients with GI 
bleeding. Most of the studies in the literature 
on the use of CT in evaluation of GI bleeding 
focused on patients with acute bleeding. In this 
group of patients, a CT examination with thin 
collimation, rapid intravenous administration of 
contrast material, and appropriate scan timing 
with acquisition of an arterial phase, yielding an 
angiographic study, may be beneficial in identify-
ing the exact source of the bleeding. In patients 
with silent OGIB, a standard CT examination of 
the abdomen and pelvis could demonstrate larger 
lesions, whereas CT techniques involving small 
bowel luminal distention, like CT enterography 
and CT enteroclysis, may be beneficial in identi-
fying small enhancing bowel wall lesions.
These special CT techniques are reviewed in 
the next sections.
CT enterography and enteroclysis
CT examination of the small bowel is a recently 
developed diagnostic tool for evaluation of small 
bowel disease. The introduction of neutral oral 
contrast agents with improved luminal distention 
and advances in CT technology have converged 
to provide new CT imaging techniques specific 
for the small bowel known as CT enterography 
and CT enteroclysis. Whereas in CT enterography 
luminal distention is achieved by ingestion (11), in 
CT enteroclysis contrast medium is administered 
into the small intestine through a nasojejunal tube 
under fluoroscopic guidance (12).
Technique.—Recently, a multiphasic CT enterog-
raphy-enteroclysis protocol has been introduced 
for evaluation of OGIB (13). Because of the 
requirement for rapid, multiphase imaging, this 
technique should be performed on at least a 
16-row multidetector scanner. After a 6-hour 
fast, patients are given a total of 1200–1600 mL 
of neutral oral contrast agent, either through a 
tube at a rate of 60–120 mL/min (CT enterocly-
sis) or divided into four oral doses given every 20 
minutes, beginning 60 minutes before scanning; 
the last dose is administered with the patient on 
the CT table just before scanning (CT enterog-
raphy). Intravenous administration of a spasmo-
lytic drug is essential before image acquisition to 
minimize patient discomfort and bowel motion 
artifact (11–13).
During intravenous injection of 150 mL of 
iodinated contrast material at a rate of 4 mL/sec 
through an antecubital catheter, bolus trigger-
ing is performed by placing a region-of-interest 
cursor over the descending aorta 2 cm above the 
diaphragm. The region-of-interest trigger thresh-
old is set at 150 HU, with scanning initiated 6 
seconds later. Scanning is performed from the 
diaphragm to the symphysis pubis during each 
of three phases: (a) a bolus-triggered arterial 
phase, (b) at 20–25 seconds (enteric phase), and 
(c) at 70–75 seconds (delayed phase) after the 
beginning of the arterial phase acquisition. Axial 
images are reconstructed with a 2-mm section 
width and 1-mm interval. Coronal images are 
reformatted from the retroperitoneal border to 
the anterior abdominal wall with a 2-mm section 
width and 1-mm interval.
Identification of the Bleeding Cause.—The 
isotropic spatial resolution provided with newer 
multidetector CT systems allows us to visualize 
small vascular lesions responsible for bleeding in 
multiple orthogonal planes. The use of neutral 
enteric contrast material provides a background 
against which enhancing bowel wall lesions (Figs 
1–5) and active bleeding can be detected (13).
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Figure 3. Polypoid jejunal lesion in a 53-year-old man with positive results from a fecal occult blood test. Coro-
nal (a) and sagittal (b) MIP enteric phase images from CT enterography show a hyperattenuating polypoid lesion 
(arrow) in the jejunum.
Figure 2. Radiation enteritis in a 72-year-old woman with colicky abdominal pain and unexplained anemia. She 
had undergone external-beam radiation therapy to the pelvis for cervical carcinoma. Axial (a) and coronal (b) maxi-
mum intensity projection (MIP) enteric phase images from CT enterography show ileal luminal narrowing and a 
thickened enhanced bowel wall (arrow), findings consistent with radiation enteritis.
Indications and Advantages.—CT enterogra-
phy and enteroclysis improve visualization of the 
small bowel mucosa and wall in comparison with 
traditional CT and fluoroscopic studies by dis-
tending the small bowel. Although CT enterog-
raphy is performed with oral hyperhydration, CT 
enteroclysis requires placement of an enteroclysis 
tube, often in patients who are unable to orally 
consume that amount of liquid. When tolerated, 
CT enterography is often preferred owing to its 
lack of invasiveness.
In patients with OGIB, these techniques may 
help determine the cause of the bleeding lesion, 
allowing improved interventional planning and 
lesion-directed planning. Similarly to other CT 
techniques, another advantage is the possibility 
of depicting extraintestinal disease (Figs 1, 4) 
(13–15). CT enterography and enteroclysis are 
indicated in silent OGIB, with no data favoring 
one technique over the other (15,16). The long 
and relatively complex preexamination prepara-
tion precludes the use of these techniques in 
clinically overt OGIB (13).
Disadvantages.—The three-phase acquisition 
results in substantial patient radiation exposure. 
Another major limitation of CT enterography-en-
Teaching
Point
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Figure 5. Adenocarcinoma in a 60-year-old man with anemia and subacute bowel obstruction. Coro-
nal (a) and sagittal (b) MIP portal venous phase images from CT enteroclysis show parietal thickening 
and enhancement of the proximal jejunum (arrow in a, circle in b), resultant marked stenosis, and dila-
tation of the proximal small bowel. The surgical specimen revealed adenocarcinoma.
Figure 4. Gastrointestinal stromal tumor in a 92-year-old man with anemia and positive results from a 
fecal occult blood test. (a) Axial enteric phase CT image shows aneurysmal dilatation of the terminal 
ileum (arrow). (b) Coronal MIP enteric phase image from CT enteroclysis shows aneurysmal dilatation 
of the terminal ileum by an exophytic mass (bottom arrow). There is one hepatic metastasis (top arrow). 
The surgical specimen revealed a gastrointestinal stromal tumor.
CT Angiography
Recent advances in CT technology have greatly 
expanded the diagnostic role of CT angiography 
for various pathologic processes. Although still 
teroclysis is the impossibility of performing thera-
peutic maneuvers. These techniques do not allow 
prolonged imaging times, which are necessary for 
detection of intermittent bleeding. Preexisting 
high-attenuation material within the bowel may 
limit the detection of active bleeding.
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within the bowel lumen that could be confused 
with hemorrhage. After administration of intra-
venous contrast material, enteric phase images 
should be obtained (17).
Figure 6. Active colonic bleeding in a 69-year-old man 
with massive hematochezia from an ileotransversostomy. 
(a) Axial unenhanced CT image shows a fluid-filled trans-
verse colonic loop (arrow). (b, c) Axial arterial phase (b) 
and portal phase (c) CT images, obtained at the same level, 
show highly attenuating extravasated contrast material 
(arrow) in the lumen of the transverse colon. (d, e) Axial (d) 
and coronal (e) MIP CT images show active bleeding into 
the transverse colon (arrow).
undergoing study, CT angiography seems to be a 
promising noninvasive diagnostic tool in the eval-
uation of OGIB, particularly the overt variant.
Technique.—CT angiography requires no special 
preparation. The acquisition technique is similar to 
that of CT enterography-enteroclysis, only differing 
in the choice of scanning phases. In patients with 
overt OGIB, an unenhanced CT scan should be 
obtained immediately before CT angiography to 
identify any preexisting hyperattenuating areas 
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Figure 8. Jejunal varices in a 59-year-old man with melena and anemia. (a) Axial portal venous phase conventional 
CT image shows thrombosis of the superior mesenteric vein (circle) and high-attenuation dilated and tortuous va-
riceal structures along the jejunal wall (arrows). (b) Coronal MIP portal venous phase CT image shows high-attenu-
ation dilated and tortuous variceal structures along the jejunal wall (arrows), findings indicative of jejunal varices.
Figure 7.  Large vascular lesion in a 71-year-old man with massive hematochezia. (Results of colonoscopy were 
inconclusive owing to excess fluid and massive hemorrhage.) (a) Axial unenhanced conventional CT image shows 
fluid-filled colonic loops. (b) Axial enteric phase conventional CT image, obtained at the same level, shows highly 
attenuating extravasated contrast material (arrow) in the lumen of the descending colon. The patient underwent sur-
gical treatment, which confirmed the presence of a large vascular lesion.
Identification of the Bleeding Cause.—The 
CT angiographic diagnosis of active GI bleed-
ing is made when hyperattenuating extravasated 
contrast material not present at unenhanced CT 
is seen within the bowel lumen (Figs 6, 7) (18). 
Evaluation of GI bleeding with CT angiography 
may also provide etiologic information in many 
cases, especially with lower GI bleeding, as has 
been demonstrated in the evaluation of colonic 
vascular lesions, with a sensitivity of 70% and 
specificity of 100% when compared with colonos-
copy and conventional angiography (19).
Distinguishing diverticular from angiodysplas-
tic bleeding (when possible) is important because 
of the prognostic differences between these two 
lesions. CT angiography can also help accurately 
diagnose neoplasms and colitis, the third and 
fourth most common causes of lower GI bleed-
ing, respectively (17). Rare causes of OGIB, like 
jejunal varices (Fig 8) and aortoenteric fistula 
(Fig 9), can also be found.
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Figure 9.  Aortoenteric fistula in a 73-year-old man with a history of aortic repair who presented with acute anemia 
and melena. Axial arterial phase (a) and portal venous phase (b) conventional CT images show inflammatory altera-
tions and gas surrounding the aortic graft. The fourth portion of the duodenum is closely adjacent to the aorta, with 
a fistulous tract (arrow) between the two structures.
Figure 10. Intraluminal accu- 
mulation of radiotracer activity 
in a 75-year-old man who pre-
sented with intermittent bright 
rectal bleeding. Dynamic radi-
onuclide images of the abdo-
men, obtained 30 minutes (a), 
2 hours (b), 3 hours (c), and 4 
hours (d) after intravenous ad-
ministration of 99mTc-labeled 
RBCs, show a focus of inter-
mittent bleeding (circle in b 
and d) in the left lower quad-
rant. The bleeding was from a 
distal small bowel source.
Indications and Advantages.—Strengths of this 
technique include noninvasiveness and sensitiv-
ity for low rates of bleeding (0.5 mL/min) (20). 
CT angiography is rapid and easy to perform in 
comparison with conventional angiography.
Yoon et al (17) conducted a CT angiographic 
study of 26 consecutive patients with acute GI 
RG  •  Volume 30  Number 1  Graça et al  243
Figure 11. Increasing intensity of intraluminal radiotracer activity over time in a 79-year-old woman who pre-
sented with melena. Dynamic radionuclide images of the abdomen, obtained 1 hour (a), 2 hours (b), 3 hours (c), 
4 hours (d), 5 hours (e), 6 hours (f), and 7 hours (g) after intravenous administration of 99mTc-labeled RBCs,  
show a focus of bleeding (arrow in f and g) in the ileum. The bleeding focus is apparent beginning at 5 hours.
bleeding. Their preliminary study demonstrated 
good overall location-based sensitivity, specificity, 
accuracy, positive predictive value, and negative 
predictive value for CT angiography in detection 
and localization of GI bleeding (17).
In the setting of acute lower GI bleeding, we 
find CT angiography a useful triaging tool to 
(a) obviate an angiographic examination with 
negative findings, (b) localize the site of bleed-
ing, (c) determine whether surgery or emboliza-
tion should be the next treatment, (d) discover 
abnormal vascular anatomy that may preclude or 
modify the approach to angiography, and (e) obtain 
additional information about the pathologic condi-
tion and the prognosis for the cause of bleeding.
CT angiography can also assist in determining 
the endoscopic approach, especially when clinical 
localization of bleeding to the upper or lower GI 
tract is difficult or unreliable. This situation may 
occur because endoscopy often fails to depict 
the exact focus of bleeding when massive bleed-
ing (>1 mL/min) occurs, since excessive blood 
or clots in the gastroduodenal tract impair the 
endoscopic view (21). Conversely, localization of 
bleeding within the small bowel may prevent un-
necessary endoscopic examinations while expe-
diting endovascular or surgical interventions.
Disadvantages.—As with all CT, CT angiogra-
phy results in substantial patient radiation expo-
sure, although this disadvantage is mitigated by 
the fact that most patients are elderly and their 
disease may be life-threatening in the short term. 
CT angiography does not permit therapeutic ma-
neuvers nor prolonged imaging times, which are 
necessary for detection of intermittent bleeding. 
Preexisting high-attenuation material within the 
bowel may also limit detection of active bleeding.
Radionuclide imaging
Scintigraphy of GI bleeding is most commonly 
performed with technetium 99m (99mTc)–labeled 
red blood cells (RBCs); this technique allows 
acute and delayed imaging owing to the persis-
tence of labeled RBCs in the circulation. Tagged 
RBC scanning is considered to be the standard of 
reference for detection of active lower GI bleed-
ing, as it reportedly allows detection of active 
bleeding at a rate of 0.10 mL/min (22).
Technique.—Twenty mL of RBCs are tagged 
with technetium and then reinjected into the 
patient. In general, images are obtained every 3 
seconds for the first minute, every 5 minutes for 
the next 45 minutes, and then every 15–60 min-
utes according to the clinical setting (22).
Identification of the Bleeding Cause.—Criteria 
for identifying the site of GI bleeding include 
intraluminal accumulation of radiotracer activ-
ity (Fig 10), increasing intensity of intraluminal 
activity over time (Fig 11), and movement of the 
radiotracer on successive images, a finding con-
sistent with intraluminal transit. In this way, it is 
possible to determine the presence or absence of 
bleeding and, where appropriate, the most likely 
source of the bleeding (23).
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Figures 12, 13. (12) Active GI hemorrhage in a 67-year-old woman with melena and bleeding that obscured endo-
scopic findings. (a) Selective angiogram of the gastroduodenal artery shows contrast material extravasation into the du-
odenal lumen (arrow). (b, c) Gastroduodenal artery (b) and celiac trunk (c) angiograms, obtained after coil emboliza-
tion (arrow), show stoppage of the GI bleeding. (13) Active GI hemorrhage in an 82-year-old man with hematochezia. 
(a) Colonoscopic image of the right colon shows a large quantity of blood, which obscures the colonoscopic findings. 
(b) Selective angiogram of the ileocolic artery shows contrast material extravasation into the colonic lumen (arrow). 
(c) Ileocolic artery angiogram obtained after coil embolization (arrow) shows stoppage of the GI bleeding.
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Indications and Advantages.—Tagged RBC 
scanning is the most sensitive technique for de-
tecting active GI bleeding and offers advantages 
in being noninvasive, not requiring special prepa-
rations for the patient, and allowing detection of 
both arterial and venous bleeding sites, whereas 
catheter-directed angiography allows detection 
of only arterial bleeding. Moreover, tagged RBC 
scanning offers the capability of imaging over a 
prolonged period, making it useful for detecting 
intermittent bleeding (Fig 10). Because of its 
mode of action, radionuclide scanning of bleed-
ing is not useful in the setting of silent OGIB.
Disadvantages.—In patients with OGIB, there 
are several drawbacks to nuclear scanning. First, 
the ability to localize the source of bleeding with 
radionuclide scanning, especially in the foregut, 
has been repeatedly demonstrated to be poor; 
even a positive scan does not allow determina-
tion of the cause of the bleeding. In addition, 
because nuclear scanning is not therapeutic, a 
follow-up study, such as catheter-directed an-
giography or endoscopic examination, must be 
subsequently performed (24).
Catheter-directed Angiography
Catheter-directed angiography is more likely to 
demonstrate an exact location of the bleeding 
if the rate is greater than 0.5 mL/min (25). In 
addition, it allows identification of nonbleeding 
lesions (eg, vascular ectasias, tumors, and inflam-
matory lesions) on the basis of their vascular 
patterns. Interventional radiologists may also 
administer specific embolization therapy if the 
lesion is amenable to such therapy.
If results of standard angiography are negative, 
provocative angiography may be considered. In 
this type of study, anticoagulants, vasodilators, 
and thrombolytics are used to provoke bleeding 
and increase the likelihood that a bleeding source 
will be found (26). Because these tests could ini-
tiate uncontrolled bleeding, they are rarely used 
and are usually not recommended.
Technique.—Catheter-directed angiography for 
GI bleeding is usually performed from a common 
femoral artery access with the Seldinger technique. 
Upper extremity arterial access can be used when 
femoral access is not possible; upper extremity 
access may even be necessary, as it often provides 
better angles for catheterization of mesenteric 
vessels relative to the abdominal aorta. A 4-F or 
5-F cobra or Simmons catheter is typically chosen 
for selection of the superior mesenteric artery, and 
diagnostic angiography is performed with 30–35 
mL of nonionic contrast material injected at a rate 
of 5–6 mL/sec. For selection of the inferior mesen-
teric artery, a 5-F Simmons II catheter is typically 
chosen, and diagnostic angiography is performed 
with 15–20 mL of nonionic contrast material 
injected at 2–3 mL/sec.
Selective catheterization for upper GI bleed-
ing includes the celiac and superior mesenteric 
arteries; for lower GI bleeding, selective cath-
eterization includes the superior and inferior 
mesenteric arteries. The initial artery catheter-
ized is the one most suspected of bleeding on the 
basis of prior imaging or endoscopic results; this 
would of course be the celiac artery for upper GI 
bleeding. For lower GI bleeding, if bleeding from 
the descending and sigmoid colon is suspected, 
then inferior mesenteric angiography should be 
performed initially, before the bladder is filled 
with contrast material, to maximize detection of 
small lesions (27).
Identification of the Bleeding Cause.—Contrast 
material extravasation into the bowel lumen is the 
definitive angiographic sign of active GI hemor-
rhage (Figs 12, 13), but for extravasation to be 
visualized, bleeding must be active at a minimum 
rate of 0.5 mL/min (25). Indirect signs of bleeding 
include contrast material filling of spaces outside 
the bowel lumen (diverticula), vascular tufts (Fig 
14) and early draining veins (angiodysplasia), 
hyperemia (colitis), neovascularity (tumor), pseu-
doaneurysm, or arteriovenous fistula (28).
Embolization of the bleeding vessel (Figs 12, 
13) is the mainstay of transcatheter treatment of 
nonvariceal GI bleeding, and high technical and 
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Figure 14. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) in a 45-year-old man 
with anemia, epistaxis, and oral telangiectases. Images from catheter-directed angiography of the mesenteric 
vessels show small telangiectases in the dependence of the colon (arrows in a) and a larger vascular malforma-
tion in the wall of the left colon (arrow in b).
clinical success rates have been reported (29). 
Microcoil embolization is typically preferred 
within the lower GI tract (30), whereas contro-
versy exists about the optimal agent within the 
upper GI tract. Common embolic agents include 
microcoils, polyvinyl alcohol particles, Gelfoam 
(absorbable gelatin sponge; Pharmacia & Upjohn, 
Kalamazoo, Mich), n-butyl cyanoacrylate glue, 
and enbucrilate tissue adhesive.
Indications and Advantages.—Catheter-directed 
angiography seems to be useful in patients with 
overt OGIB. Ideally, these patients should first 
be evaluated with CT angiography, to localize 
the bleeding lesion and plan the approach to 
catheter-directed angiography. Patients with early 
positive nuclear scans, postoperative patients, 
and patients with severe bleeding not diagnosed 
or unable to be treated with endoscopy are also 
suitable to be studied preferentially with catheter-
directed angiography. Catheter-directed angiog-
raphy is generally reserved for specific situations 
in which other modalities have failed. One of its 
greatest advantages is the ability to localize the 
bleeding site and perform therapeutic interven-
tions upon detection. This technique is not useful 
in patients with silent OGIB because the blood 
loss is often too low to be detected (4).
Disadvantages.—In patients with OGIB, the 
major drawbacks to catheter-directed angiogra-
phy are the invasive nature of the procedure; the 
associated risks related to vascular access and 
other catheter-related complications (the most 
feared by far has been bowel ischemia); the risk 
of contrast material reactions; and the impos-
sibility of achieving prolonged imaging times, 
preventing the detection of intermittent bleed-
ing (25,27–30).
Figure 15. Close-up (a) and pan-
oramic (b) photographs of a wireless 
capsule endoscope (PillCam; Given 
Imaging, Yoqneam, Israel).
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Figure 16. Results of wireless capsule endoscopy in four patients with OGIB. Images 
from capsule endoscopy show small bowel lesions suspected of being responsible for bleed-
ing: angiodysplasias (arrows in a and b), bleeding ileal ulceration (arrow in c), and a jejunal 
tumor (arrows in d).
Wireless Capsule endoscopy
The development of capsule endoscopy has 
permitted direct visualization of the small bowel 
mucosa. So far, OGIB is the main clinical indi-
cation for capsule endoscopy; about 70%–80% 
of patients undergoing capsule endoscopy have 
OGIB (31,32).
Technique.—Capsule endoscopy uses a 26 × 
11-mm plastic capsule (Fig 15), which contains 
four light-emitting diodes, a lens, a camera, two 
batteries, and a radiofrequency transmitter. Pa-
tients typically undergo preprocedure preparation 
(ranging from simple fasting to cathartic cleans-
ing) to clear the GI tract (32).
After the patient swallows the capsule, it is 
passively propelled by peristalsis and captures 
images of the entire length of the small intestine, 
transmitting the data to a recording device worn 
by the patient. Images are transmitted by radio-
frequency to an eight-point abdominal sensory ar-
ray taped to the patient’s abdomen and recorded 
on a portable digital recorder worn on a belt. The 
images are viewed with dedicated software after 
downloading to a computer workstation. The 
procedure is completely ambulatory. The patient 
is not confined to a medical institution and is al-
lowed to continue daily activities (32).
Identification of the Bleeding Cause.—The most 
common findings include vascular lesions, small 
bowel malignancies, and small bowel ulcerations 
(Fig 16). Several studies have further supported 
the role of capsule endoscopy in the evaluation of 
OGIB, with an overall diagnostic yield between 
50% and 70% (33–35).
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To reduce this risk, patients with high suspicion 
of bowel narrowing (history of nonsteroidal anti-
inflammatory drug use, Crohn disease, occlusive 
symptoms, or ischemic bowel disease) should 
undergo capsule endoscopy only after undergoing 
other techniques, such as CT enterography-en-
teroclysis, small bowel series, or exploration with 
a patency capsule (38).
Double-Balloon enteroscopy
Yamamoto et al (39) established a new double-
balloon insertion method for enteroscopy. This 
method enables endoscopic inspection of the en-
tire small bowel with interventional capabilities.
Technique.—The double-balloon enteroscopy 
system (Fig 17) consists of a high-resolution 
video endoscope with a working length of 200 
Figure 17.  Double-balloon enteroscope. (a) Close-up 
photograph shows the insufflated latex balloons at the 
distal end of the enteroscope. (b, c) Photographs show 
an overall view (b) and the controller mechanisms (c) of 
the enteroscope.
Indications and Advantages.—Capsule endos-
copy is currently the preferred test for mucosal 
imaging of the entire small intestine and seems 
to be most useful in patients with a history of 
recent active bleeding (33). Subgroup analysis 
shows that the diagnostic yield is much higher in 
patients with ongoing overt OGIB than in those 
with silent OGIB. Current data suggest that 
the timing of the procedure is very important 
in optimizing the yield of capsule endoscopy in 
OGIB (36). The International Conference on 
Capsule Endoscopy consensus meeting on OGIB 
recommended that capsule endoscopy should be 
performed early (preferably within 2 weeks) in 
the work-up of patients with OGIB (37).
Disadvantages.—The main limitations of capsule 
endoscopy are the lack of air insufflation, the 
unavailability of rinsing, and the inability to per-
form biopsies or treat lesions (31,33,34). As with 
conventional endoscopy of the upper and lower 
GI tract, the presence of massive hemorrhage can 
obscure the bleeding site (21).
There is a risk of retention of the endoscopic 
capsule, estimated at less than 1% and generally 
related to the presence of endoluminal narrowing. 
Teaching
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Figure 18. Results of double-balloon enteroscopy in four patients with OGIB. Images from 
double-balloon enteroscopy show small bowel lesions suspected of being responsible for 
bleeding: angiodysplasias (arrows in a and b), ileal ulceration (arrow in c), and jejunal ad-
enocarcinoma (arrow in d). Arrow in b = angiodysplasia treated with argon plasma.
cm. Latex balloons are attached at the tip of the 
enteroscope, and the overtube is inflated and 
deflated with air. The scope can be advanced by 
mouth or per anus by using the balloons in a 
pushing and pulling manner to pleat the small 
bowel over the scope and visualize the small 
intestine. This method allows insertion deep into 
the small bowel in steps of 20 cm on average 
and is also known as push-and-pull enteroscopy. 
Endoscope insertion to the distal small intestine 
is generally carried out from an anal approach.
As preparation for double-balloon enteros-
copy, the patient must fast overnight for the oral 
approach; for the anal approach, preparation is 
the same as for colonoscopy. For all lesions ob-
served with double-balloon enteroscopy, biopsy 
specimens are obtained and the lesion is treated 
as necessary (39).
Identification of the Bleeding Cause.—Diagnostic 
or therapeutic success is achieved in 55%–75% 
of examinations, a result comparable to those of 
other diagnostic modalities in the small bowel. 
This method is likely to be one of the better 
techniques for detection and treatment of mucosal 
lesions. The most common findings include small 
bowel vascular lesions followed by ulcerations and 
malignancies (Fig 18) (40).
Indications and Advantages.—One of the main 
advantages of double-balloon enteroscopy is that 
it not only allows confirmation of the diagnosis 
suspected with capsule endoscopy or radiologic 
examination, but also allows biopsy and thera-
peutic approaches in most patients with OGIB. 
Teaching
Point
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Figure 19. Algorithm for the imaging work-up of patients with OGIB. DB = 
double-balloon, Mes = mesenteric.
Endoscopic therapeutic treatment may be by in-
jection (epinephrine, alcohol) or may be thermal 
(Fig 18a, 18b) (heater probe, electrocoagulation, 
laser) (40).
Disadvantages.—In patients with OGIB, the ma-
jor limitations to double-balloon enteroscopy are 
the impossibility of visualizing the entire small 
bowel in one examination; limited availability; 
the presence of massive hemorrhage, which can 
obscure the bleeding site; and the associated risks 
of pancreatitis and visceral perforation (41).
Clinical Scenarios and Diag- 
nostic and Therapeutic Approach
The diagnostic and therapeutic approach to 
patients with OGIB will vary according to the 
clinical presentation of the bleeding. Figure 
19 offers a suggested systematic approach to 
diagnosis and treatment of OGIB according to 
the clinical presentation. This guideline has not 
been clinically validated.
Silent OGiB
Patients presenting with silent OGIB who have 
previously undergone upper endoscopy and 
colonoscopy should undergo repeat upper endos-
copy or colonoscopy (4). A significant number 
will have an identifiable lesion found with these 
procedures. If no lesions are seen, the patient 
should undergo CT enterography-enteroclysis. 
Although there are no data favoring CT enterog-
raphy over CT enteroclysis in this clinical situa-
tion, the former is often preferred due to its lack 
of invasiveness. CT enteroclysis is reserved for 
patients who are unable to orally consume the 
required amount of liquid.
If a lesion is visualized with CT enterography-
enteroclysis, the patient should be treated accord-
ingly. If that study shows no lesion, the next step 
will be capsule endoscopy. If a lesion is detected, 
double-balloon enteroscopy should be performed 
with diagnostic and therapeutic intentions. Cath-
eter-directed angiography should be reserved 
for the selected rare cases of silent OGIB where 
no diagnosis is obtained. If no lesions are seen, 
efforts to control the OGIB with pharmacologic 
therapy should be considered.
Overt OGiB
If the patient is in hemodynamically stable condi-
tion, we recommend repeating upper endoscopy 
and colonoscopy (4). If results are negative, tagged 
RBC scanning is our next diagnostic step. If results 
of radionuclide scanning are positive, the following 
step should be catheter-directed angiography with 
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therapeutic intentions. If the patient is actively 
bleeding and in unstable condition or results of 
radionuclide scanning are negative, CT angiogra-
phy is indicated, followed by catheter-directed an-
giography if a bleeding source is identified. When 
significant bleeding is ongoing despite a thorough 
evaluation with negative results, laparotomy and 
intraoperative enteroscopy should be performed. If 
the patient is in stable condition and results of all 
these studies are negative, the OGIB is reclassified 
to the silent type.
Conclusions
OGIB is a relatively common problem facing 
internists, gastroenterologists, and surgeons in a 
typical clinical practice. There are multiple imag-
ing modalities that are currently being used in 
the evaluation of OGIB. To optimize patient care, 
the radiologist must be familiar with the common 
causes of OGIB and the strengths and weaknesses 
of the various available imaging examinations.
Recognition of the cause and site of OGIB is 
instrumental to guide treatment planning, and 
the various imaging approaches should be tai-
lored according to the clinical scenario.
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CT enterography and enteroclysis are indicated in silent OGIB, with no data favoring one technique 
over the other (15,16). 
 
Page 243 
CT angiography can also assist in determining the endoscopic approach, especially when clinical 
localization of bleeding to the upper or lower GI tract is difficult or unreliable. This situation may 
occur because endoscopy often fails to depict the exact focus of bleeding when massive bleeding (>1 




Tagged RBC scanning is the most sensitive technique for detecting active GI bleeding and offers 
advantages in being noninvasive, not requiring special preparations for the patient, and allowing 
detection of both arterial and venous bleeding sites, whereas catheter-directed angiography allows 
detection of only arterial bleeding. Moreover, tagged RBC scanning offers the capability of imaging 
over a prolonged period, making it useful for detecting intermittent bleeding (Fig 10). 
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Capsule endoscopy is currently the preferred test for mucosal imaging of the entire small intestine and 
seems to be most useful in patients with a history of recent active bleeding (33). 
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One of the main advantages of double-balloon enteroscopy is that it not only allows confirmation of 
the diagnosis suspected with capsule endoscopy or radiologic examination, but also allows biopsy and 
therapeutic approaches in most patients with OGIB. 
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